Molecular mechanism of respiratory syncytial virus fusion inhibitors.
Battles, M.B., Langedijk, J.P., Furmanova-Hollenstein, P., Chaiwatpongsakorn, S., Costello, H.M., Kwanten, L., Vranckx, L., Vink, P., Jaensch, S., Jonckers, T.H., Koul, A., Arnoult, E., Peeples, M.E., Roymans, D., McLellan, J.S.(2016) Nat Chem Biol 12: 87-93
- PubMed: 26641933 
- DOI: 10.1038/nchembio.1982
- Primary Citation of Related Structures:  
5EA3, 5EA4, 5EA5, 5EA6, 5EA7, 5EA8 - PubMed Abstract: 
Respiratory syncytial virus (RSV) is a leading cause of pneumonia and bronchiolitis in young children and the elderly. Therapeutic small molecules have been developed that bind the RSV F glycoprotein and inhibit membrane fusion, yet their binding sites and molecular mechanisms of action remain largely unknown ...